Abstract
Active prevention of coronary heart disease (CHD) should be started early in life and focus on prevention of arterial disease. Secondary prevention however should primarily focus on the risk of death and myocardial protection. The two main causes of death in these patients are sudden cardiac death (SCD) and heart failure (HF), often resulting from myocardial ischemia and subsequent necrosis. In that context, it is crucial to understand that our populations are chronically and severely deficient in some major nutrients in particular ω-3 polyunsaturated fatty acids (n-3 PUFA). Actually, consumption of n-3 PUFA is inversely correlated with the risk of SCD, the first cause of death in CHD patients. On the other hand, the main mechanism underlying recurrent cardiac events is myocardial ischemia resulting from atherosclerotic plaque rupture or ulceration. Plaque rupture is usually the consequence of intraplaque inflammation in relation with a high lipid content of the lesion, high concentration of leukocytes and lipid peroxidation products. Thus, in patients with established CHD, the three main aims of the preventive strategy are to prevent malignant ventricular arrhythmias and SCD (1), the development of severe ventricular dysfunction and heart failure (2), and to minimize the risk of plaque inflammation and ulceration ( 3|3}). For that purpose, the adoption of a Mediterranean diet rich in ω-3 fatty acids seems to be the most effective strategy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
de Lorgeril M, Salen P, Defaye P, et al. Dietary prevention of sudden cardiac death. Eur Heart J 2002;23:277–285.
Zheng ZJ, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158–2163.
Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART). Lancet 1989;2:757–761.
Leaf A, Kang JX, Xiao YF, et al. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003;107:2646–2652.
Kris-Etherton PM, Shaffer Taylor D, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71(suppl):179S–188S.
De Caterina A, Zampoli R. From asthma to atherosclerosis-5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 2004;350:4–7.
de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454–1459.
Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995;274:1363–1367.
Albert CM, Hennekens CH, O’Donnel CJ, et al. Fish consumption and the risk of sudden cardiac death. JAMA 1998;279:23–28.
GISSI-Prevenzione investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447–455.
Schrepf R, Limmert T, Wever PC, et al. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004;363:1441–1442.
Leaf A, Albert CM, Josephson M, Steinhaus D, Kugler J, Kang JX, Cox B, Zhang H, Schoenfeld D, for the Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005;112:2762–2768.
de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation 1999;99:779–785.
Guiraud A, de Lorgeril M, Boucher F, et al. Cardioprotective effect of chronic low dose ethanol drinking. Insights into the concept of ethanol preconditioning. J Mol Cell Cardiol 2004;36:561–566.
Albert CM, Manson JE, Cook NR, et al. Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 1999;100:944–950.
Albert CM, Ma J, Rifai N, et al. Prospective study of C-Reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002;105:2595–2599.
Albert CM, Chae CU, Grodstein F, et al. Prospective study of sudden cardiac death among women in the United States. Circulation 2003;107:2096–2101.
Heart Protection Study Collaborative Group. MRC:BHF heart protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7–22.
Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623–1630.
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs. usual care: the Antihypertensive and Lipid-Lowering Treatment to prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998–3007.
Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than average cholesterol concentrations in the Anglo-Scandinavian Cardiac Outcomes Trial —Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149–1158.
Koren MJ, Hunninghake DB, ALLIANCE Investigators. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering diseases management clinics. The ALLIANCE Study. JACC 2004;44:1772–1779.
Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243–2249.
Schwarz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: a randomized controlled trial. JAMA 2001;285:1711–1718.
Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495–1504.
Cowie MR, Mostred A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997;18:208–225.
Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115–126.
de Lorgeril M, Latour JG. Leukocytes, thrombosis and unstable angina. N Engl J Med 1987;316:1161.
Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915–924.
Kris-Etherton P, Eckel R, Howard B, St. Jeor S, Bazzarre T. Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on cardiovascular disease. Circulation 2001;103:1823–1825.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
de Lorgeril, M., Salen, P. (2008). Dietary Prevention of Coronary Heart Disease. In: De Meester, F., Watson, R.R. (eds) Wild-Type Food in Health Promotion and Disease Prevention. Humana Press. https://doi.org/10.1007/978-1-59745-330-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-330-1_17
Publisher Name: Humana Press
Print ISBN: 978-1-58829-668-9
Online ISBN: 978-1-59745-330-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)